Can the vitality of youth be transferred through a simple blood transfusion?

Can the vitality of youth be transferred through a simple blood transfusion?
Image: Intellect (generated)

In short: From 17th-century experiments involving sheep's blood to modern clinical trials with lab-grown cells, the quest to rejuvenate the aging body via blood remains a scientific frontier. While mouse studies show promise for organ and memory repair, the human reality is a complex landscape of high-cost promises and stern regulatory warnings.

The concept of 'amending bad blood' dates back to the 1660s. Early pioneers like Sir Christopher Wren and Dr. William Croone conducted experiments on animals, observing that a spaniel could survive receiving blood from another dog. Human trials were even more radical; in 1667, a 32-year-old man named Arthur Coga received roughly twelve ounces of sheep's blood, a procedure he chose for its symbolic religious significance. While Coga survived, modern science warns that inter-species compatibility is highly problematic.

Modern interest focuses on 'heterochronic parabiosis'—the surgical joining of circulatory systems in animals of different ages. In mice, these studies have suggested that young blood can rejuvenate stem cells, improve memory, and even repair hypertrophied hearts. However, the mechanism is debated. Some researchers, like Amy Wagers, note that mouse studies do not provide a definitive scientific basis for human trials, and others suggest the benefits might stem from access to a partner's organs rather than the blood itself.

The commercialization of this science has led to significant controversy. Startups like Ambrosia have offered young plasma transfusions for up to $12,000, prompting a sharp rebuke from the FDA. The agency stated that such infusions provide 'no proven clinical benefit' against aging or Alzheimer’s and can pose serious risks. While the future may lie in safer, lab-grown red blood cells—currently being tested in the RESTORE trial to study cell lifespan—the leap from rodent rejuvenation to human anti-aging therapy remains unproven and ethically fraught.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/health-young-blood-transfusion.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…